ALLO

Allogene Therapeutics Inc

Jun 12 • 04:00PM ET

1.90

+0.02 1.06 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: SANA KRYS BMRN RYTM KYMR INCY NUVL VKTX AXSM NBIX

| Held by: VTI XBI IWM VXF IBB IWN FESM SCHA DFAS VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.77	Insider Own	24.58%	Shs Outstand	345.15M	Perf Week	1.06%
Market Cap	655.79M	Forward P/E	-	EPS next Y	-0.75	Insider Trans	-0.34%	Shs Float	260.30M	Perf Month	-18.45%
Enterprise Value	469.95M	PEG	-	EPS next Q	-0.17	Inst Own	39.02%	Short Float	17.09%	Perf Quarter	-20.83%
Income	-173.76M	P/S	-	EPS this Y	19.26%	Inst Trans	7.12%	Short Ratio	4.45	Perf Half Y	28.38%
Sales	0.00M	P/B	1.67	EPS next Y	-6.71%	ROA	-38.45%	Short Interest	44.48M	Perf YTD	38.69%
Book/sh	1.14	P/C	2.46	EPS next 5Y	7.44%	ROE	-52.32%	52W High	4.46 -57.40%	Perf Year	35.71%
Cash/sh	0.77	P/FCF	-	EPS past 3/5Y	28.61% 16.08%	ROIC	-49.43%	52W Low	0.98 93.05%	Perf 3Y	-66.90%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.09% 7.00%	Perf 5Y	-92.72%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	37.45%	Oper. Margin	-	ATR (14)	0.15	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.65	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	41.94	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	9.65	EPS Q/Q	36.09%	SMA20	-4.59%	Beta	0.49	Target Price	8.48
Payout	-	Debt/Eq	0.29	Sales Q/Q	-	SMA50	-14.48%	Rel Volume	0.86	Prev Close	1.88
Employees	152	LT Debt/Eq	0.26	Earnings	May 13 AMC	SMA200	9.08%	Avg Volume	10.00M	Price	1.90
IPO	Oct 11, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.31% -100.00%	Trades		Volume	8,636,227	Change	1.06%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)